We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




POC Urinalysis System Evaluated for Schistosomiasis

By LabMedica International staff writers
Posted on 02 Jul 2019
Print article
Image: The CLINITEK Status+ analyzer provides results for routine urine tests, kidney disease and pregnancy tests (Photo courtesy of Siemens Healthineers).
Image: The CLINITEK Status+ analyzer provides results for routine urine tests, kidney disease and pregnancy tests (Photo courtesy of Siemens Healthineers).
Schistosoma haematobium is one of the three main human species of digenetic trematodes, belonging to a group of blood flukes, and causes the urinary form of schistosomiasis and remains a significant public health problem worldwide, despite years of efforts to control it.

Hematuria is one of the notable indirect indicators of S. haematobium infection and is commonly assessed along with other routine screens using a urinary dipstick test. A portable “field friendly” electronic analyzer would offer an automated and thus more objective read-out compared to visual-read dipstick methods.

Medical scientist associated with the Swiss Tropical and Public Health Institute (Basel, Switzerland) collected urine samples as part of a Phase 2 dose-finding clinical trial with praziquantel in S. haematobium-infected children. Collectively, 174 school-aged and 170 preschool-aged children were enrolled in the trial, which took place in November 2015 in Côte d’Ivoire.

The team compared a visual-read of the urine dipstick strips Multistix PRO to the automated reader CLINITEK Status+ analyzer, also manufactured by Siemens Healthcare Diagnostics. For the leukocyte, urobilinogen, proteins, blood, ketone bodies and bilirubin parameters, findings were compared employing linear weighted Cohen’s kappa (κ) coefficient statistic. Results were then also stratified according to infection intensity using WHO standards for S. haematobium infection intensity classification: egg count of 1 to 49 eggs per 10 mL urine was regarded as light; and egg count of ≥ 50 eggs/10 mL urine was regarded as heavy infection.

The team reported that the children harbored predominantly light intensity infections (83.7% of samples) and this was true for both pre-school-aged (90.5% of samples) and school-aged children (72.4% of samples). Of the children found to have eggs in their urine, hematuria was detected in 64.3% of their samples by visual read-out and in 63.0% of their samples by machine read-out. The observed agreement between the two techniques was fair for bilirubin and ketone bodies, moderate for urobilinogen and proteins, good for leukocytes, and very good for nitrites and hematuria.

The authors concluded that the agreement between visual and automated readout of the Multistix Pro urine dipsticks was fair to moderate for most parameters. However, a very good agreement was observed for hematuria and nitrites, two parameters in detecting S. haematobium as well as urinary tract infections, which are often associated with schistosomiasis. The findings reaffirm that, although hematuria might be a good indicator of morbidity due to urinary schistosomiasis, its utility as a diagnostic tool in areas of low-intensity infections is dubious, therefore underscoring the urgent need for more sensitive point-of-care diagnostic tools. The study was published on June 13, 2019, in the journal Parasites & Vectors.

Related Links:
Swiss Tropical and Public Health Institute

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.